Anti-GPC3 antibody drug conjugates
TW202626740APending Publication Date: 2026-07-01ABBVIE INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114150357
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-12-19
- Filing Date
- 2025-12-19
- Publication Date
- 2026-07-01
Abstract
The present disclosure provides GPC3 antibody drug conjugates (ADCs), including compositions and methods of using such ADC.
Need to check novelty before this filing date? Find Prior Art